DistressOther
BioXcel Therapeutics, Inc. acquired target
Public M&A record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
BioXcel Therapeutics, Inc. -> target · $57.5 million
The CRO will report to a Strategic Process Committee of the Board that was appointed pursuant to the Prepetition Credit Agreement in order to evaluate, negotiate, oversee, coordinate and implement any sale, restructuring or other material transactions, includi
Open source record (SEC) ↗